Nitric oxide signaling is disrupted in the yeast model for Batten disease

• Autor(a) principal: Osório, Nuno S.
• Data de Publicação: 2007
• Outros Autores: Carvalho, Agostinho, Almeida, Agostinho J., Padilla-Lopez, Sérgio, Leão, Cecília, Laranjinha, João, Ludovico, Paula, Pearce, David A., Rodrigues, Fernando
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/1822/67735
• topic: Apoptosis; Biomarkers; Cell Nucleus; Cyclins; Humans; Microbial Viability; Models, Biological; Mutation; Neuronal Ceroid-Lipofuscinoses; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Time Factors; Vitamin K 3; Signal Transduction; Ciências Médicas::Medicina Básica; Ciências Médicas::Biotecnologia Médica; Science & Technology

The juvenile form of neuronal ceroid lipofuscinoses (JNCLs), or Batten disease, results from mutations in the CLN3 gene, and it is characterized by the accumulation of lipopigments in the lysosomes of several cell types and by extensive neuronal death. We report that the yeast model for JNCL (btn1-Delta) that lacks BTN1, the homologue to human CLN3, has increased resistance to menadione-generated oxidative stress. Expression of human CLN3 complemented the btn1-Delta phenotype, and equivalent Btn1p/Cln3 mutations correlated with JNCL severity. We show that the previously reported decreased levels of L-arginine in btn1-Delta limit the synthesis of nitric oxide (.NO) in both physiological and oxidative stress conditions. This defect in .NO synthesis seems to suppress the signaling required for yeast menadione-induced apoptosis, thus explaining btn1-Delta phenotype of increased resistance. We propose that in JNCL, a limited capacity to synthesize .NO directly caused by the absence of Cln3 function may contribute to the pathology of the disease.